Literature DB >> 21704271

Restriction enzyme-mediated enhanced detection of circulating cell-free fetal DNA in maternal plasma.

John A Tynan1, Payam Mahboubi, Lesley L Cagasan, Dirk van den Boom, Mathias Ehrich, Paul Oeth.   

Abstract

A universal method confirming the presence of circulating cell-free fetal (ccff) DNA in maternal plasma is important in the field of noninvasive prenatal diagnostics. Restriction endonuclease digestion of one allele of a single-nucleotide polymorphism (SNP) was used to allow detection of paternal alleles in maternal plasma DNA. Multiplexed genotyping of 92 panethnic high-frequency SNPs predicted >0.99 probability of detecting at least four informative loci per sample. Child-maternal paired DNA samples were used to confirm detection of 2% child's heterozygous DNA in a background of maternal DNA homozygous for the digestible allele. By restriction endonuclease digestion of DNA in a PCR cocktail before thermal cycling, 10 genomic copies of a paternal SNP allele were detectable in a background of 990 maternal SNP alleles. A comparison of 154 pregnant and nonpregnant female plasma DNA samples demonstrated enhanced detection of nondigestible SNP alleles in maternal plasma. Receiver operating characteristic curve analysis showed an optimal detection threshold of four nondigestible SNP alleles in plasma for the confirmation of ccff DNA and 98% sensitivity and 96% specificity at a 95% confidence level. Our study demonstrates the ability of this technique to confirm the presence of paternal alleles from ccff DNA in maternal plasma.
Copyright © 2011 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21704271      PMCID: PMC3123783          DOI: 10.1016/j.jmoldx.2011.02.001

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  18 in total

1.  Detection of rare mutant alleles by restriction endonuclease-mediated selective-PCR: assay design and optimization.

Authors:  C J Fuery; H L Impey; N J Roberts; T L Applegate; R L Ward; N J Hawkins; C A Sheehan; R O'Grady; A V Todd
Journal:  Clin Chem       Date:  2000-05       Impact factor: 8.327

2.  The International HapMap Project.

Authors: 
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

3.  MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis.

Authors:  Chunming Ding; Rossa W K Chiu; Tze K Lau; Tse N Leung; Li C Chan; Amy Y Y Chan; Pimlak Charoenkwan; Ivy S L Ng; Hai-Yang Law; Edmond S K Ma; Xiangmin Xu; Chanane Wanapirak; Torpong Sanguansermsri; Can Liao; Mary Anne Tan Jin Ai; David H K Chui; Charles R Cantor; Y M Dennis Lo
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

4.  Analysis of the size distributions of fetal and maternal cell-free DNA by paired-end sequencing.

Authors:  H Christina Fan; Yair J Blumenfeld; Usha Chitkara; Louanne Hudgins; Stephen R Quake
Journal:  Clin Chem       Date:  2010-06-17       Impact factor: 8.327

5.  Quantification of fetal DNA by use of methylation-based DNA discrimination.

Authors:  Anders O H Nygren; Jarrod Dean; Taylor J Jensen; Selena Kruse; William Kwong; Dirk van den Boom; Mathias Ehrich
Journal:  Clin Chem       Date:  2010-08-20       Impact factor: 8.327

6.  Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.

Authors:  Y M Lo; M S Tein; T K Lau; C J Haines; T N Leung; P M Poon; J S Wainscoat; P J Johnson; A M Chang; N M Hjelm
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

7.  Reliability of fetal sex determination using maternal plasma.

Authors:  Peter G Scheffer; C Ellen van der Schoot; Godelieve C M L Page-Christiaens; Bernadette Bossers; Femke van Erp; Masja de Haas
Journal:  Obstet Gynecol       Date:  2010-01       Impact factor: 7.661

8.  Restriction endonuclease-mediated selective polymerase chain reaction: a novel assay for the detection of K-ras mutations in clinical samples.

Authors:  R Ward; N Hawkins; R O'Grady; C Sheehan; T O'Connor; H Impey; N Roberts; C Fuery; A Todd
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

9.  Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum.

Authors:  D W Bianchi; G K Zickwolf; G J Weil; S Sylvester; M A DeMaria
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

Review 10.  Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed.

Authors:  C Ellen van der Schoot; G H Martine Tax; Robbert J P Rijnders; Masja de Haas; Godelieve C M L Christiaens
Journal:  Transfus Med Rev       Date:  2003-01
View more
  4 in total

1.  An SNP panel for the analysis of paternally inherited alleles in maternal plasma using ion Torrent PGM.

Authors:  Donggui Yang; Hao Liang; Shaobin Lin; Qing Li; Xiaoyan Ma; Jun Gao; Hongyu Sun; Qingqing Chen; Jianzhu Wu; Xueling Ou
Journal:  Int J Legal Med       Date:  2017-04-20       Impact factor: 2.686

2.  Quantification of cell-free DNA in normal and complicated pregnancies: overcoming biological and technical issues.

Authors:  Irina Manokhina; Tanjot K Singh; Maria S Peñaherrera; Wendy P Robinson
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

3.  Noninvasive Prenatal Paternity Testing (NIPAT) through Maternal Plasma DNA Sequencing: A Pilot Study.

Authors:  Haojun Jiang; Yifan Xie; Xuchao Li; Huijuan Ge; Yongqiang Deng; Haofang Mu; Xiaoli Feng; Lu Yin; Zhou Du; Fang Chen; Nongyue He
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

4.  Akonni TruTip(®) and Qiagen(®) methods for extraction of fetal circulating DNA--evaluation by real-time and digital PCR.

Authors:  Rebecca C Holmberg; Alissa Gindlesperger; Tinsley Stokes; David Lopez; Lynn Hyman; Michelle Freed; Phil Belgrader; Jeanne Harvey; Zheng Li
Journal:  PLoS One       Date:  2013-08-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.